Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
Canaccord Adams Downgrades St. Jude Medical Inc. (STJ) to Hold
-
David Moenning's Daily State of the Markets: Voting With Their Feet
-
Lime Energy (LIME) Completes Sale of 750K Over-Allotment Option Shares
-
David Moenning's Daily State of the Markets: Expecting Too Much?
-
Canaccord Adams Downgrades ResMed (RMD) to Hold
-
EnteroMedics (ETRM) to Offer 6.16M Shares at $0.80/Share
-
Canaccord Adams Lifts Price Target on Fuel Systems (FSYS) to $40
-
Canaccord Adams Initiates Coverage on Allergan (AGN) with a Buy; Global Leader with Robust Pipeline
-
Canaccord Adams Initiates Coverage on Solta Medical (SLTM) with a Buy
-
Canaccord Adams Initiates Coverage on Palomar Medical Technologies (PMTI) with a Buy
-
Canaccord Adams Initiates Coverage on Cynosure (CYNO) with a Buy
-
Canaccord Adams Initiates Coverage on Cutera (CUTR) with a Hold
-
Canaccord Adams Maintains a 'Buy' on Northern Oil and Gas (NOG); Raises PT
-
Canaccord Adams Maintains a 'Buy' on Brigham Exploration (BEXP); Raises Price Target
-
Canaccord Adams Maintains a 'Hold' on Companhia Vale do Rio Doce (VALE); Raises PT
-
Canaccord Adams Raises Price Target On Inverness Medical (IMA) to $49, Citing Pima System
-
Canaccord Adams Reiterates a 'Buy' on ATP Oil & Gas (ATPG); Attractively Priced Name To Own
-
Canaccord Adams Maintains a 'Buy' on Freeport McMoRan (FCX); Raises Target Price
-
Canaccord Adams Downgrades Cameco Corporation (CCJ) to Hold; Full Valuation
-
David Moenning's Daily State of the Markets: Losing Their Appetite?
-
Canaccords Adams Says Buy Research In Motion (RIMM) On Weakness
-
Headwaters (HW) Closes 9.6M Share Offering, Raising $34.5M in Net Proceeds
-
Google (GOOG) Clears $500 Hurdle
-
David Moenning's Daily State of the Markets: Strike Oneā¦
-
Canaccord Adams Raises Price Target on IAC/InterActiveCorp. (IACI) to $22, Sees More Share Buybacks
-
Canaccord Adams Starts HeartWare International (HTWR) at Buy
-
Canaccord Adams Starts Protalix BioTherapeutics (PLX) at Buy
-
Canaccord Adams Raises Price Target On Google (GOOG) to $560
-
Canaccord Adams Upgrades Magma Design (LAVA) to Buy
-
Morning Movers 9/18: BPFH, IOC, HEAT, LAVA, EROC Higher; FSP, ARNA, EDR, NMM Lower
-
Canaccord Adams Upgrades Rubicon Technology (RBCN) to Buy, Doubles Price Target
-
Omeros (OMER) Sees IPO Price of $10-$12
-
Canaccord Adams Transitions Coverage to a 'Hold' on Standard Microsystems (SMSC); Issues Q3 and FY'10 Estimates
-
Canaccord Adams Reiterates a 'Sell' on Palm (PALM); Valuation Too Rich
-
Canaccord Adams Reinstates a 'Buy' Rating on EnCana Corporation (ECA)
-
Headwaters (HW) Agrees to Sell 9.6M Shares at $3.90
-
Canaccord Adams Downgrades Omniture (OMTR) to Hold
-
Canaccord Adams Upgrades Emulex (ELX) to Buy
-
Canaccord Adams Upgrades Spectranetics (SPNC) to Buy
-
Canaccord Adams Reiterates a 'Buy' on National Semiconductor (NSM); Raises Price Target & Estimates
-
Canaccord Adams Reiterates a 'Buy' on Texas Instruments (TXN); Upside on High Performance Analog
-
NeuroMetrix (NURO) Announces Commitments from Institutional Investors to Buy $18.68M in Common Shares
-
Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded
-
Canaccord Adams Initiates Coverage on Kadant (KAI) with a Buy
-
Canaccord Adams Downgrades Hologic (HOLX) to Hold
-
Unusual 11 Mid-Day Movers 8/26: NYMX, VG, SOMX, USEG Higher; CASM, CCUR, ISLE, DY Lower
-
David Moenning's Daily State of the Markets: 8/26
-
Morning Movers 8/26: VG, GSAT, HGSI, MYGN Higher; CCUR, CASM, ISLE, BPI Lower
-
Canaccord Adams Downgrades Netezza (NZ) to Hold
-
Canaccord Adams Upgrades Myriad Genetics (MYGN) to Buy

